Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)

Tundra lists 1 Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07679269

Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.

The purpose of this study is to provide post-trial access to alpelisib and to assess its long-term safety when administered as a single agent or in combination with other drugs. This study is intended for participants who are currently receiving alpelisib in a Novartis-sponsored clinical trial (parent study) and, in the Investigator's judgment, would benefit from continued treatment with alpelisib.

Gender: All

Updated: 2026-09-18

Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)